CRISPR helps identify potential Alzheimer's-related protein

Experts have identified a new protein in the pathway that leads to Alzheimer's disease. Researchers used the 'molecular scissors' of CRISPR/Cas9 to search for new genes related to the neurodegenerative disease. Researchers tested a total of 19,150 individual genes for their effect on amyloid beta levels and ruled out all but one: calcium and integrin-binding protein 1 (CIB1).